Skip to main content

Thoracic Surgery

0
Pipeline Programs
6
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

6 companies ranked by most advanced pipeline stage

Grifols
GrifolsNEW YORK, NY
1 program
AlbuminN/A1 trial
Active Trials
NCT02878733Completed6,249Est. Mar 2013
Getinge
GetingeChina - Suzhou
1 program
High-flow nasal cannulaN/A1 trial
Active Trials
NCT03877172Unknown40Est. Dec 2020
MSD
MSDIreland - Ballydine
1 program
intraoperative neuromuscular blockadeN/A1 trial
Active Trials
NCT03503565Completed118Est. May 2021
Merck & Co.
Merck & Co.RAHWAY, NJ
1 program
intraoperative neuromuscular blockadeN/A
Sharp Therapeutics
Sharp TherapeuticsPA - Pittsburgh
1 program
intraoperative neuromuscular blockadeN/A
Edwards Lifesciences
1 program
pulmonary artery catheterN/A1 trial
Active Trials
NCT02964026Completed6,844Est. Nov 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GetingeHigh-flow nasal cannula
MSDintraoperative neuromuscular blockade
Edwards Lifesciencespulmonary artery catheter
GrifolsAlbumin

Clinical Trials (4)

Total enrollment: 13,251 patients across 4 trials

NCT03877172GetingeHigh-flow nasal cannula

High Flow Nasal Cannula in Thoracic Surgery: a Physiologic Study

Start: Feb 2020Est. completion: Dec 202040 patients
N/AUnknown
NCT03503565MSDintraoperative neuromuscular blockade

Intraoperative Neuromuscular Blockade and Postoperative Atelectasis

Start: Oct 2018Est. completion: May 2021118 patients
N/ACompleted
NCT02964026Edwards Lifesciencespulmonary artery catheter

Study of Clinical Outcomes Associated With the Pulmonary Artery Catheter (PAC) in Cardiac Surgery Patients

Start: Sep 2016Est. completion: Nov 20166,844 patients
N/ACompleted
NCT02878733GrifolsAlbumin

Albumin Administration and Outcomes in Cardiac Surgery

Start: Jan 2012Est. completion: Mar 20136,249 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

6 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.